Faculty Disclosures

Article Outline

• Policy on Faculty and Sponsor Disclosure
• Faculty
• CME Reviewer
• Medical Director

Back to Article Outline

Policy on Faculty and Sponsor Disclosure 

As a sponsor accredited by the ACCME, it is the policy of the University of Wisconsin School of Medicine and Public Health to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or sponsor has with either the commercial supporter(s) of this activity or the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The faculty reported the following:

Back to Article Outline

Faculty 

Dominick J. Angiolillo, MD, PhD, has served on the advisory boards of Accumetrics, Inc, Arena Pharmaceuticals, Inc, Bristol-Myers Squibb Company/sanofi-aventis, Eli Lilly and Company/Daiichi Sankyo, Inc, Medicure, Inc, The Medicines Company, Novartis, and Portola Pharmaceuticals, Inc; acted as an investigator for Accumetrics, Inc, AstraZeneca PLC, Eisai Inc, Eli Lilly and Company/Daiichi Sankyo, Inc, GlaxoSmithKline PLC, The Medicines Company, Otsuka, Portola Pharmaceuticals, Inc, and Schering-Plough Corporation; and has served as a speaker for Bristol-Myers Squibb Company/sanofi-aventis and Eli Lilly and Company/Daiichi Sankyo, Inc.

Deepak L. Bhatt, MD, MPH, has served as a consultant to, or served on the advisory boards of AstraZeneca PLC, Bristol-Myers Squibb Company, Cardax Pharmaceuticals, Inc, Centocor, Inc, Cogentus Pharmaceuticals, Daiichi Sankyo, Inc, Eisai Inc, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson & Johnson, McNeil, Inc, The Medicines Company, Medtronic, Inc, Millennium Pharmaceuticals, Inc, Otsuka America Pharmaceutical, Inc, ParinGenix Inc, PDL BioPharma, Inc, Philips, Portola Pharmaceuticals, Inc, sanofi-aventis, Schering-Plough Corporation, Scios Inc, TNS Healthcare PLC, and Vertex Pharmaceuticals, Inc; has received honoraria from AstraZeneca PLC, Bristol-Myers Squibb Company, Centocor Inc, Daiichi Sankyo, Inc, Eisai Inc, Eli Lilly and Company, GlaxoSmithKline PLC, The Medicines Company, Millennium Pharmaceuticals, Inc, ParinGenix Inc, PDL BioPharma, Inc, sanofi-aventis, Schering-Plough Corporation, and TNS Healthcare PLC; has received research grants from Bristol-Myers Squibb Company, Eisai Inc, Ethicon Inc, Heartscape Technologies Inc, The Medicines Company, and sanofi-aventis; and has acted as a speaker for Bristol-Myers Squibb Company, The Medicines Company, and sanofi-aventis

Paul A. Gurbel, MD, has received research grants from AstraZeneca PLC, Bayer AG, Haemoscope Corporation, Millennium Pharmaceuticals, Inc, the National Institutes of Health, and Schering-Plough Corporation

Lisa K. Jennings, PhD, has served on the advisory boards of AstraZeneca PLC, Bristol-Myers Squibb Company/sanofi-aventis, and Schering-Plough Corporation; and has received a research grant from Schering-Plough Corporation

Alan D. Michelson, MD, has served as a consultant to Eli Lilly and Company/Daiichi Sankyo, Inc; received honoraria from sanofi-aventis/Bristol-Myers Squibb Company; and has received research grants from Accumetrics, Inc, Arena Pharmaceuticals, Inc, Dade Behring Inc, Eli Lilly and Company/Daiichi Sankyo, Inc, GL Synthesis, Inc, McNeil Consumer Healthcare, and sanofi-aventis/Bristol-Myers Squibb Company

Matthew J. Price, MD, has served as a consultant to Accumetrics, Inc and Volcano Corporation; and acted as a speaker for Boston Scientific Corporation, Cardis Corporation, and The Medicines Company

Back to Article Outline

CME Reviewer 

Peter S. Rahko, MD, has received honoraria from GlaxoSmithKline PLC and Novartis

Back to Article Outline

Medical Director 

Bruce Greenberg, PhD, is a stockholder in Wyeth

Notice: The University of Wisconsin School of Medicine and Public Health advises the participants that this CME activity does not contain reference(s) to unlabeled or unapproved uses of drugs or devices.